NASDAQ: GLSI - Greenwich LifeSciences, Inc.

Yield per half year: +14.66%
Sector: Healthcare

Share chart Greenwich LifeSciences, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About

Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which is in Phase III clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

EBITDA -0.0034
Число акций ао 0.01285 млрд
P/BV 16.09
EV/EBITDA 0.0018
Цена ао 20.32
ISIN US3968791083
Сайт https://greenwichlifesciences.com
Валюта usd
IPO date 2020-09-25
Sector Health Care
Industry Biotechnology
Валюта отчета usd
Change price per day: -2.27% (14.16)
Change price per week: +6.86% (12.95)
Change price per month: -7.31% (14.93)
Change price per 3 month: -10.89% (15.53)
Change price per half year: +14.66% (12.07)
Change price per year: +64.65% (8.405)
Change price per 3 year: -62.43% (36.84)
Change price per year to date: +25.81% (11)
All parameters

Underestimation

Title Value Grade
P/S 0 0
P/BV 21.32 1
P/E 0 0
EV/EBITDA -14.57 0
Total: 1.63

Efficiency

Title Value Grade
ROA, % -127.12 0
ROE, % -132.71 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA 0 10
Total: 9.8

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 174.24 10
Yield EPS, % 141.81 10
Total: 8
More

Institutions Volume Share, %
Vanguard Group Inc 221682 1.73
Blackrock Inc. 57148 0.44
Ameriprise Financial, Inc. 53647 0.42
Geode Capital Management, LLC 46816 0.36
Renaissance Technologies, LLC 36600 0.28
Northern Trust Corporation 20983 0.16
683 Capital Management LLC 19604 0.15
Qube Research & Technologies Ltd 14714 0.11
JANE STREET GROUP, LLC 14005 0.11
State Street Corporation 13002 0.1

ETF Share, % Profitability for 1 year, % Dividends, %
ProShares Hedge Replication ETF 0.0005 5.9237999659878 1.47892
iShares Micro-Cap ETF 0.02306 36.318555985322 1.54048
iShares Russell 2000 Growth ETF 0.00627 38.042556988 0.6026
ProShares UltraPro Russell2000 0.00192 89.821266282945 1.47873
Vanguard Russell 3000 ETF 0 31.87314172448 1.43817
Vanguard Russell 2000 Growth ETF 0.01 39.350070246167 0.60264
Vanguard Russell 2000 ETF 0 35.648084105685 1.48801



Head Job title Payment Year of birth
Mr. Snehal S. Patel CEO, CFO & Director 1.09M 1964 (60 years)
Mr. Eric Rothe Founder & Independent Director 65.64k 1976 (48 years)
Dr. Frank Joseph Daugherty M.D. Chief Medical Officer & Director N/A 1951 (73 years)
Dr. Jaye L. Thompson Ph.D. Vice President Clinical & Regulatory Affairs N/A 1966 (58 years)
Dr. Christine T. Fischette Ph.D. VP of Business Development N/A 1951 (73 years)

Address: United States, Stafford. TX, Building 14 - open in Google maps, open in Yandex maps
Website: https://greenwichlifesciences.com